Thrombolytic therapy of pulmonary embolism
- 1 November 2002
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (9) , 1660-1667
- https://doi.org/10.1016/s0735-1097(02)02381-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Alteplase improves the clinical course of patients with major pulmonary embolism: a multicenter, randomized, placebo-controlled trial (management strategies and prognosis in pulmonary embolism study 3)Journal of the American College of Cardiology, 2002
- Funnel plots for detecting bias in meta-analysisJournal of Clinical Epidemiology, 2001
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Pulmonary embolism thromboiysis: A clarion call for international collaborationJournal of the American College of Cardiology, 1992
- Methods for combining randomized clinical trials: Strengths and limitationsStatistics in Medicine, 1987
- A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary EmbolismActa Medica Scandinavica, 1978
- Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary EmbolismBMJ, 1974
- ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISMThe Lancet, 1960